VEPTR is based on a three-dimensional thoracic approach to treat patients with complex chest wall and/or spinal deformities where the thorax is unable to support normal respiration or lung growth (Thoracic Insufficiency Syndrome). Additionally VEPTR devices control and may correct scoliosis. VEPTR is designed to mechanically stabilize and distract the thorax to improve respiration and lung growth in infantile and juvenile patients.
Devices are attached perpendicularly to the patient’s natural ribs (superior attachment point) and more caudal ribs, a lumbar vertebra or to the ilium (inferior attachment point).Once the VEPTR device is in place, its design allows expansion, anatomic distraction, and replacement of components through less-invasive surgery.
All components of the VEPTR II system are manufactured from a titanium alloy (Ti-6Al-7Nb) with the exception of the Ala-hook and S-rod, which are manufactured from commercially pure titanium.
Goals of treatment
- Increase thoracic volume
- Scoliosis correction
- Improve thoracic function
- Establish thoracic symmetry by lengthening the concave, restricted hemithorax
- Avoid growth-inhibiting procedures
- Maintain these improvements throughout the patient’s growth
About DePuy Synthes
Founded 1895 in Warsaw, Indiana, by Revra DePuy, DePuy operates as a brand under the Johnson &Johnson Medical organization.On April 27, 2011,DePuy and Synthes agreed to a merger deal. The DePuy Synthes Companies offer the world’s most comprehensive portfolio of orthopaedic and neuro products and services for joint reconstruction, trauma, spine, sports medicine, neuro, cranio-maxillofacial, power tools and biomaterials. http://www.depuysynthes.com